This medication is taken by injection.
Glatopa® is the generic equivalent of Copaxone (glatiramer acetate). The U.S. Food and Drug Administration (FDA) has approved Glatopa as substitutable for Copaxone 20mg (taken daily) and Copaxone 40mg (taken 3 times a week).
Glatiramer acetate is a synthetic protein that simulates myelin basic protein, a component of the myelin that insulates nerve fibers in the brain and spinal cord. This drug seems to block myelin-damaging T-cells through a mechanism that is not completely understood.
Glatopa is approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Click here to read the FDA Prescribing Information for healthcare professionals. To read the Patient Information for Glatopa, go to Medication Guide.
GLATOPA SUPPORT PROGRAM
Financial Assistance Program